Stockscreener 앱 받기
99.62
1.46%
1.42
전일 마감가:
$98.20
열려 있는:
$99.58
하루 거래량:
345.39K
Relative Volume:
0.15
시가총액:
$19.00B
수익:
$8.41B
순이익/손실:
$760.80M
주가수익비율:
25.87
EPS:
3.8513
순현금흐름:
$1.05B
1주 성능:
+2.47%
1개월 성능:
+9.35%
6개월 성능:
+1.41%
1년 성능:
-2.85%
1일 변동 폭
$98.27
$100.38
1주일 범위
$94.28
$101.16
52주 변동 폭
$79.12
$108.29
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
99.62 | 19.20B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
112.69 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.68 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.55 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.20 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.26 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-23 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2026-02-20 | 개시 | William Blair | Mkt Perform |
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Grandfield & Dodd LLC Buys New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
J.P. Morgan Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $117 - Moomoo
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zimmer Biomet stock edges lower as investors weigh Q2 2026 cash flow and $1 billion buyback plan - AD HOC NEWS
297,894 Shares in Zimmer Biomet Holdings, Inc. $ZBH Bought by Alberta Investment Management Corp - MarketBeat
Zimmer Biomet Holdings (ZBH) Could Be 2% Undervalued As Q2 Beat Lifts The Story - Sahm
Everett Harris & Co. CA Invests $2.55 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Chintan Desai Net Worth (2026) - GuruFocus
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative - Sahm
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend? - TradingView
Are Wall Street Analysts Bullish on Zimmer Biomet Stock? - Barchart.com
5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call - Yahoo Finance
Handelsbanken Fonder AB Buys 28,130 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) sees Dodge & Cox disclose 12.5% ownership stake - Stock Titan
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next? - TradingView
Zimmer Biomet reports strong second quarter financial results - Today's Medical Developments
Donald TrumpZIMMER BIOMET HOLDINGS INC Trump Trade on May. 11, 2026 - Quiver Quantitative
Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake - Stock Titan
Assenagon Asset Management S.A. Buys 97,887 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00 - MarketBeat
Price to earnings forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Strong Potential Upside with Robust Analyst Ratings - DirectorsTalk Interviews
Zimmer Biomet Q2 Earnings Call Highlights - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Q2 2026 Zimmer Biomet Holdings, Inc Earnings Call Transcript - GuruFocus
Wall Street Zen Downgrades Zimmer Biomet (NYSE:ZBH) to Hold - MarketBeat
Wells Fargo Adjusts Price Target on Zimmer Biomet to $103 From $90 - Moomoo
Wilsey Asset Management Inc. Has $36.32 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Truist Adjusts Price Target on Zimmer Biomet to $106 From $92, Maintains Hold Rating - marketscreener.com
Zimmer Biomet Holdings (ZBH) Following Its Beat And Guidance Lift, Is The Valuation Catching Up? - Yahoo Finance
Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH) Stock forecasts - Yahoo Finance Singapore
Baird Adjusts Zimmer Biomet Price Target to $104 From $92 - Moomoo
Zimmer Biomet Holdings (ZBH) Gets a Buy from TD Cowen - The Globe and Mail
RBC Capital Adjusts Price Target on Zimmer Biomet to $110 From $101, Maintains Outperform Rating - Moomoo
Bernstein Adjusts Price Target on Zimmer Biomet to $93 From $91 - marketscreener.com
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $104.9, Implies 7% Upside - TradingView
Leerink Partners Adjusts Price Target on Zimmer Biomet to $106 From $90 - marketscreener.com
JPMorgan Adjusts Price Target on Zimmer Biomet to $117 From $95 - marketscreener.com
UBS Adjusts Price Target on Zimmer Biomet to $120 From $115, Maintains Buy Rating - marketscreener.com
Deutsche Bank Adjusts Zimmer Biomet Price Target to $98 From $88, Maintains Hold Rating - marketscreener.com
Zimmer Biomet sales force revamp going better than expected, CEO says - Yahoo Finance
Renaissance Technologies LLC Invests $5.47 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Needham reiterates Hold on Zimmer Biomet stock after Q2 beat By Investing.com - Investing.com Nigeria
Bank of America Corp DE Purchases 249,175 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ZIMMER BIOMET HOLDINGS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $106.00 FROM $90.00 - Bitget
Zimmer Biomet Holdings, Inc. : Leerink Partne - Moomoo
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $99.58, Implies 4% Upside - TradingView
Zimmer Biomet Holdings Inc (ZBH) (Q2 2026) Earnings Call Highlights: Strong Sales Beat and ... - Yahoo Finance
Zimmer Biomet Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
자본화:
|
볼륨(24시간):